ACR.AX
Price:
$0.033
Market Cap:
$13.27M
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.[Read more]
Industry
Biotechnology
IPO Date
2004-09-29
Stock Exchange
ASX
Ticker
ACR.AX
According to Acrux Limited’s latest financial reports and current stock price. The company's current ROE is -130.13%. This represents a change of 222.08% compared to the average of -40.40% of the last 4 quarters.
The mean historical ROE of Acrux Limited over the last ten years is -46.49%. The current -130.13% ROE has changed 179.89% with respect to the historical average. Over the past ten years (40 quarters), ACR.AX's ROE was at its highest in in the December 2013 quarter at 41.92%. The ROE was at its lowest in in the June 2024 quarter at -78.17%.
Average
-46.49%
Median
-42.64%
Minimum
-177.05%
Maximum
29.58%
Discovering the peaks and valleys of Acrux Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 8.45%
Maximum Annual ROE = 29.58%
Minimum Annual Increase = -101.87%
Minimum Annual ROE = -177.05%
Year | ROE | Change |
---|---|---|
2024 | -177.05% | 1.92% |
2023 | -8.79% | -91.88% |
2022 | -108.18% | 58.23% |
2021 | -68.37% | -7.24% |
2020 | -73.71% | 94.22% |
2019 | -37.95% | -19.80% |
2018 | -47.32% | 8.45% |
2017 | -0.55% | -101.87% |
2016 | 29.58% | 7.96% |
2015 | 27.40% | -58.80% |
The current ROE of Acrux Limited (ACR.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-98.01%
5-year avg
-87.22%
10-year avg
-46.49%
Acrux Limited’s ROE is greater than Pharmaxis Ltd (-143.13%), greater than Starpharma Holdings Limited (-26.10%), greater than Bionomics Limited (-116.12%), less than Antisense Therapeutics Limited (0%), greater than Ainsworth Game Technology Limited (-2.85%),
Company | ROE | Market cap |
---|---|---|
-143.13% | $20.23M | |
-26.10% | $45.99M | |
-116.12% | $13.22M | |
0% | $52.29M | |
-2.85% | $250.91M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acrux Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acrux Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Acrux Limited's ROE?
How is the ROE calculated for Acrux Limited (ACR.AX)?
What is the highest ROE for Acrux Limited (ACR.AX)?
What is the 3-year average ROE for Acrux Limited (ACR.AX)?
What is the 5-year average ROE for Acrux Limited (ACR.AX)?
How does the current ROE for Acrux Limited (ACR.AX) compare to its historical average?